Edesa Biotech (EDSA) Long-Term Investments (2016 - 2018)
Edesa Biotech (EDSA) posted Long-Term Investments of $46456.0 for Q3 2018, down 30.35% sequentially from $66695.0 in Q2 2018, and down 30.35% YoY from $66695.0 in Q3 2017.
Edesa Biotech (EDSA) Long-Term Investments (2016 - 2018) Analysis & Trends
Edesa Biotech has reported Long-Term Investments for 3 years, with the latest figure at $46456.0 in Q3 2018.
- Quarterly Long-Term Investments fell 30.35% year-over-year to $46456.0 in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $46456.0 (down 30.35% YoY) and the FY2018 annual result came in at $46456.0, down 30.35% from the prior year.
- Long-Term Investments declined to $46456.0 in Q3 2018 per EDSA's latest filing, from $66695.0 in the prior quarter.
- Over five years, Long-Term Investments peaked at $67000.0 in Q3 2016 and troughed at $46456.0 in Q3 2018.
- A 3-year average of $64701.6 and a median of $66695.0 in 2016 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2017 and 2018: Long-Term Investments changed 0.0% in 2017, then plunged 30.35% in 2018.
- Over 3 years, Long-Term Investments stood at $66695.0 in 2016, then changed by 0.0% to $66695.0 in 2017, then sank by 30.35% to $46456.0 in 2018.
- According to Business Quant data, Long-Term Investments over the past three periods registered $46456.0, $66695.0, and $66695.0 for Q3 2018, Q2 2018, and Q1 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | Edesa Biotech | 40.44 Mn | 40.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 46,456.00 |
| Jun 30, 2018 | 66,695.00 |
| Mar 31, 2018 | 66,695.00 |
| Dec 31, 2017 | 66,695.00 |
| Sep 30, 2017 | 66,695.00 |
| Jun 30, 2017 | 66,695.00 |
| Mar 31, 2017 | 66,695.00 |
| Dec 31, 2016 | 66,695.00 |
| Sep 30, 2016 | 67,000.00 |
| Jun 30, 2016 | 66,695.00 |